These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Evaluation of the effectiveness of screening for tumors of the digestive system]. Franceschi S, Segnan N. Ann Ist Super Sanita; 1996; 32(4):621-7. PubMed ID: 9382431 [Abstract] [Full Text] [Related]
5. [Experience in active detection of oncological diseases at industrial enterprises in the Armenian SSR]. Mkrtchian LN, Ambartsumian AM, Magakian AG. Vopr Onkol; 1983; 29(3):87-90. PubMed ID: 6220518 [Abstract] [Full Text] [Related]
6. [Pilot study of screening for the early diagnosis of tumors of the upper respiratory and digestive tracts in individuals at risk in the Friuli-Venezia Giulia region]. Barzan L, Barra S, Caruso G, Franceschi S, Comoretto R. Acta Otorhinolaryngol Ital; 1990; 10(2):129-38. PubMed ID: 2260437 [Abstract] [Full Text] [Related]
7. [Results of a serological examination for echinococcosis in the population of the Armenian SSR and their epidemiological assessment]. Dzhambazian MP, Avakian DM, Khachatrian SS, Keshishian ASh, Davidiants VA. Med Parazitol (Mosk); 1979; 48(6):29-32. PubMed ID: 160007 [No Abstract] [Full Text] [Related]
8. [Obesity: A not well-known digestive precancerous state]. Hillon P, He F. Presse Med; 2010 Dec; 39(12):1233-5. PubMed ID: 20692799 [No Abstract] [Full Text] [Related]
10. Gastric cancer after positive screening faecal occult blood testing and negative assessment. Zappa M, Visioli CB, Ciatto S, Grazzini G, Rubeca T, Bonanomi AG, Confortini M, Paci E, Castiglione G. Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076 [Abstract] [Full Text] [Related]
11. [Organization of republican endoscopic and cytologic centers for active screening of pretumor and tumor diseases of the cervical canal and corpus uteri]. Mkrtchian LN, Ambartsumian AM, Arzumanian GA, Madoian AG, Shakhnazarian ZhS. Vopr Onkol; 1988 Apr; 34(5):605-8. PubMed ID: 2968019 [Abstract] [Full Text] [Related]
12. [The crypto-hem test in screening for colon cancer]. Prokorov VV, Shabarov VL. Vopr Onkol; 1988 Apr; 34(3):335-8. PubMed ID: 3358298 [Abstract] [Full Text] [Related]
15. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL, Smith A, Bampton PA, Cole SR, Young GP. Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514 [Abstract] [Full Text] [Related]
16. [Colorectal cancer screening: immunological test for faecal occult blood preferred]. Jansen JB, van Rossum LG, Laheij RJ. Ned Tijdschr Geneeskd; 2009 Oct; 153():A474. PubMed ID: 19785842 [Abstract] [Full Text] [Related]
18. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Qureshi WA, Rajan E, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. Gastrointest Endosc; 2006 Apr; 63(4):570-80. PubMed ID: 16564854 [No Abstract] [Full Text] [Related]
19. [Summary of a new assessment strategy in positive occult blood tests in mass screening]. Robra BP. Leber Magen Darm; 1987 Apr; 17(2):113-24. PubMed ID: 3586827 [Abstract] [Full Text] [Related]
20. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?]. Trevisani L, Cifalà V, Sartori S, Tombesi P, Matarese V, Pezzoli A, Abbasciano V. Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]